Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Italian version of the Majeed pelvic score: translation, cross-cultural adaptation and validation.

Musculoskeletal surgery·2024
Same author

Measuring gait parameters from a single chest-worn accelerometer in healthy individuals: a validation study.

Scientific reports·2024
Same author

The Musculoskeletal Tumor Society Scoring system is a valid subjective and objective tool to evaluate outcomes of surgical treatment of patients affected by upper and lower extremity tumors.

Musculoskeletal surgery·2024
Same author

Cross-cultural adaptation and validation of the Italian version of the Western Ontario Rotator Cuff (WORC) index.

Musculoskeletal surgery·2024
Same author

The systemic deletion of interleukin-1α reduces myocardial inflammation and attenuates ventricular remodeling in murine myocardial infarction.

Scientific reports·2023
Same author

Fewer cetuximab-related skin-toxicities in colorectal cancer patients treated with encorafenib: a Yin and Yang effect of ERK paradoxical activation.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Related Experiment Video

Updated: Jun 1, 2026

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

PNA-based artificial nucleases as antisense and anti-miRNA oligonucleotide agents.

M Gaglione1, G Milano, A Chambery

  • 1Environmental Sciences Department, SUN, 81100-Caserta, Italy.

Molecular Biosystems
|May 31, 2011
PubMed
Summary

Peptide Nucleic Acid (PNA)-based nucleases show promise as gene therapy agents. Nuclease B demonstrated superior performance, highlighting PNA

More Related Videos

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

Related Experiment Videos

Last Updated: Jun 1, 2026

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

Area of Science:

  • * Molecular Biology
  • * Nucleic Acid Chemistry
  • * Drug Discovery

Background:

  • * Peptide Nucleic Acid (PNA) exhibits unique chemical, physical, and biological properties.
  • * PNA is recognized for its potential in diagnostics, biosensors, and gene therapeutics, particularly in antisense (AO) and anti-miRNA (AMO) strategies.
  • * PNA-based oligonucleotides are emerging as effective agents for AO and AMO approaches.

Purpose of the Study:

  • * To design, synthesize, and characterize novel PNA-based artificial nucleases.
  • * To evaluate the nuclease activity of two distinct PNA-PEG conjugates (A and B) with different cleavage sites (HGG·Cu and DETA).
  • * To assess the potential of these PNA-based nucleases as AO and AMO agents.

Main Methods:

  • * Synthesis and characterization of PEG-PNA-PEG constructs conjugated to HGG·Cu (A) and DETA (B).
  • * Qualitative analysis using MALDI-TOF mass spectrometry.
  • * Quantitative nuclease activity assays using High-Throughput Screening (HTS) on an RNA-3'-FAM target sequence.

Main Results:

  • * Both PNA-based nucleases (A and B) demonstrated nuclease activity against the RNA target.
  • * Nuclease B exhibited superior performance compared to nuclease A.
  • * The presence of a Polyethylene Glycol (PEG) spacer was found to be relevant for cleavage efficiency, especially in conjugate A.

Conclusions:

  • * PNA-based nucleases, particularly conjugate B, show significant potential as AO and AMO agents.
  • * The study underscores the importance of the PEG spacer in enhancing the efficiency of PNA-based nucleases.
  • * These findings suggest a promising avenue for developing novel gene-modulating therapeutics using PNA technology.